Hepatology: Memorial Sloan-Kettering Cancer Center

Total Score People Score Events Score
53 49 18
Date Event Presentation Speakers
January 4, 2017 Innovations in Gastroenterology, 2017 Symposium Targeting genomic alterations of Colitis associated cancers: David Kelsen, USA David P Kelsen
October 24, 2015 19th International Meeting of the European Society of Gynaecological Oncology (ESGO 2015) Task Force: SURGEON Nadeem Abu-Rustum
January 30, 2014 Genitourinary Cancers Symposium A Decade in Review: Prostate Cancer Peter T Scardino
Welcome and General Session 4: Multimodal Management of Urothelial Carcinoma (ARS) Hikmat Al-Ahmadie
October 27, 2013 Nature - CNIO Cancer Symposium: Frontiers in Tumour Heterogeneity and Plasticity Short Talk: “Serpins shield brain metastatic cells from death signals and vascular detachment” Manuel Valiente-Cortes
May 31, 2013 ASCO Annual Meeting 2013 Multimodality Approaches to Achieving Tobacco Cessation in the Oncology Practice Jamie S. Ostroff
Optimizing the Role of Advanced Practice Professionals in Oncology Practice Dean Bajorin
Prostate Cancer Screening: Past, Present, and Future Peter T Scardino, Ethan M. Basch
Relating to Patients on a Humanistic or Spiritual Level: How Physicians Can Make a Difference (M01) Jimmie C Holland
More Mastectomies: Why? (C05) Monica Morrow
Multiplex Genetic Testing for Inherited Cancer Risk: Pros and Cons Mark Robson
Optimizing Locoregional Treatment in Early-Stage Breast Cancer Hiram S. Cody
Education Sessions Robert G Maki, Leonard Saltz
Education Sessions Ethan M. Basch
Education Sessions Kenneth Offit
Education Sessions Andrew David Zelenetz, Stuart M Lichtman, Sergio Giralt
Special Session Teresa Gilewski
April 6, 2013 AACR Annual Meetings CANCER EVOLUTION AND RESISTANCE Neal Rosen
Cross-Species Analysis of Mouse and Human Cancer Chairperson: David J. Adams, Wellcome Trust Sanger Institute, Cambridge, United Kingdom Hans-Guido Wendel
Building on the Success of CTLA-4 Blockade Through Biomarker Analyses and Development of Novel Combinatorial Strategies Chairperson: Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center, New York, NY Jedd D. Wolchok, Margaret Callahan
Use of Next-Generation Sequencing: Implementation of Clinical Genomics Chairperson: David B. Solit, Memorial Sloan-Kettering Cancer Center, New York, NY David B. Solit
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA Chris Sander
The Molecular Basis for Improvement in Endometrial Cancer Therapy Co-Chairpersons: Cheryl Lyn Walker, Texas A&M University Health Science Center, Houston, TX, and Douglas A. Levine, Memorial Sloan-Kettering Cancer Center, New York, NY Douglas A. Levine
Using Genomics to Guide Cancer Immunotherapy Chairperson: Robert D. Schreiber, Washington University School of Medicine, St. Louis, MO James P Allison
Novel Therapeutic Concepts with Kinases, Immuno-, and Radiotherapy Chairperson: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY James A. Fagin
Predictive Modeling of Cancer Treatment in Single Patients (N of 1) Moderator: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY David B. Solit
Clinical Trials Based on Mutations versus Histology Charles L Sawyers
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY Neal Rosen
Noncoding RNAs in Cancer: From Pathogenesis to Therapeutics Chairperson: Elsa R. Flores, The University of Texas MD Anderson Cancer Center, Houston, TX Andrea Ventura
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY David C Lyden
Progress in Targeting Chromatin Modifying Enzymes in Cancer Therapy Victoria M. Richon, Sanofi Oncology, Cambridge, MA Victoria M. Richon
Macrophages as a Therapeutic Target in the Tumor Microenvironment Johanna A. Joyce, Memorial Sloan-Kettering Cancer Center, New York, NY Johanna A. Joyce
January 20, 2013 Tumor Invasion and Metastasis Macrophages as a therapeutic target in invasive gliomas Johanna A Joyce
Niches and pathways of latent and overt metastasis Joan Massagué
Session 4: Metastasis Signaling Pathways Joan Massagué
October 4, 2012 14th Annual Lynn Sage Breast Cancer Symposium Z11 One Year Later: Issues and Implementation Monica Morrow
Multidisciplinary Tumor Board: Case Reviews and Audience Response Monica Morrow
Radiation Alternatives in the Older Patient: Intraoperative, Short Course, PBI Alice Ho
Obesity, Inflammation and Breast Cancer Clifford Hudis
Optimizing Reconstructive Outcomes when PMRT is Necessary Babak Mehrara
September 13, 2012 International Society of Gastrointestinal Oncology Updates on Pathologic Classification and Grading of NETs David S. Klimstra
Chemotherapy and Radiation Therapy is Necessary Preoperative Therapy David H. Ilson
Session 1 | Esophageal/Gastric Cancer David H. Ilson
Welcome From the President David H. Ilson
April 27, 2012 2012 Annual Paris Melanoma Conference An update on ipilimumab combination studies Jedd D. Wolchok
November 15, 2011 Cosa 38th Annual Scientific Meeting Challenges in development of novel therapeutics Howard Scher
June 30, 2011 2011 AHPBA Americas Post Graduate Course Advanced Interventional and Surgical Techniques to Improve Resectability for Patients with Hepatocellular Carcinoma Michael D’Angelica
February 27, 2011 AACR-NCI Conference on Systems Biology: Confronting the Complexity of Cancer Session 4 | Cancer Stem Cells/Developmental Biology Franziska Michor
Treatment of Incurable Metatstatic Colorectal Cancer Leonard Saltz
Panel Discussion With Interactive Q/A Nabil Rizk
Sparing Esophagus in Patients with Esophageal Cancer Nabil Rizk
February 17, 2008 GRC - Glycolipid & Sphingolipid Biology Discussion Richard Kolesnick
November 15, 2007 The Joint Meeting of the 4th ISC International Conference on Cancer Therapeutics and The 7th Princess Margaret Hospital Conference: New Developments in Cancer Management New targeted therapies in renal cell carcinoma Robert J. Motzer
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 6: New & Emerging Biomarkers & Drug Targets (09:00-12:00) Anh Tuan Phan
Session 6: G-quadruplex Structures of Nucleic Acids as Potential Targets for Drug Design (11:00-11:20) Anh Tuan Phan
October 16, 2007 Inaugural HDAC inhibitors: Meeting the Challenges of Chemical Development of HDAC Inhibitors Oct (16 -17) OVERCOMING THE CHALLENGES: ADVANCED HDAC INHIBITORS (08:30-11:10) Paul A. Marks
OVERCOMING THE CHALLENGES - ADVANCED HDAC INHIBITORS: Chairperson’s Remarks (08:30-08:40) Paul A. Marks
MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT: Histone Deacetylase Inhibitors: Molecular Mechanism of Action (11:10-11:40) Paul A. Marks
MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT: Panel Discussion- Are HDAC Inhibitors Proving Their Worth in the Clinic? (14:25-15:25) Howard Scher, Paul A. Marks
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.